. | . | . | Relapse free . | Recurrent . | . | P value . | |
---|---|---|---|---|---|---|---|
. | . | . | n = 15 . | . | n = 7 . | . | . |
Mean age | 61.7 | 58.7 | 0.832 | ||||
Sex | |||||||
Male | 14 | 7 | |||||
Female | 1 | 0 | 0.259 | ||||
Plasma miR-21 | |||||||
(Mean) | 1.27 | 1.7 | 0.04 | ||||
Stage | |||||||
III | 6 | 2 | |||||
IV | 9 | 5 | 0.49 | ||||
Subsite | |||||||
Oro-hypopharynx | 13 | 5 | |||||
Others | 2 | 2 | 0.378 | ||||
HPV status positive | 3 | 1 | |||||
Negative | 12 | 5 | 0.105 | ||||
Brinkman index | |||||||
≦400 | 4 | 1 | |||||
>400 | 11 | 5 | 0.651 | ||||
Sake index (mean) | 47.1 | 73.5 | 0.805 | ||||
CRP (mean) | 0.413 | 2.059 | 0.49 | ||||
NLR (mean) | 2.75 | 2.49 | 0.49 | ||||
SCC antigen (mean) | 1.66 | 2.33 | 0.112 |
. | . | . | Relapse free . | Recurrent . | . | P value . | |
---|---|---|---|---|---|---|---|
. | . | . | n = 15 . | . | n = 7 . | . | . |
Mean age | 61.7 | 58.7 | 0.832 | ||||
Sex | |||||||
Male | 14 | 7 | |||||
Female | 1 | 0 | 0.259 | ||||
Plasma miR-21 | |||||||
(Mean) | 1.27 | 1.7 | 0.04 | ||||
Stage | |||||||
III | 6 | 2 | |||||
IV | 9 | 5 | 0.49 | ||||
Subsite | |||||||
Oro-hypopharynx | 13 | 5 | |||||
Others | 2 | 2 | 0.378 | ||||
HPV status positive | 3 | 1 | |||||
Negative | 12 | 5 | 0.105 | ||||
Brinkman index | |||||||
≦400 | 4 | 1 | |||||
>400 | 11 | 5 | 0.651 | ||||
Sake index (mean) | 47.1 | 73.5 | 0.805 | ||||
CRP (mean) | 0.413 | 2.059 | 0.49 | ||||
NLR (mean) | 2.75 | 2.49 | 0.49 | ||||
SCC antigen (mean) | 1.66 | 2.33 | 0.112 |
NLR: neutrophil–lymphocyte ration
. | . | . | Relapse free . | Recurrent . | . | P value . | |
---|---|---|---|---|---|---|---|
. | . | . | n = 15 . | . | n = 7 . | . | . |
Mean age | 61.7 | 58.7 | 0.832 | ||||
Sex | |||||||
Male | 14 | 7 | |||||
Female | 1 | 0 | 0.259 | ||||
Plasma miR-21 | |||||||
(Mean) | 1.27 | 1.7 | 0.04 | ||||
Stage | |||||||
III | 6 | 2 | |||||
IV | 9 | 5 | 0.49 | ||||
Subsite | |||||||
Oro-hypopharynx | 13 | 5 | |||||
Others | 2 | 2 | 0.378 | ||||
HPV status positive | 3 | 1 | |||||
Negative | 12 | 5 | 0.105 | ||||
Brinkman index | |||||||
≦400 | 4 | 1 | |||||
>400 | 11 | 5 | 0.651 | ||||
Sake index (mean) | 47.1 | 73.5 | 0.805 | ||||
CRP (mean) | 0.413 | 2.059 | 0.49 | ||||
NLR (mean) | 2.75 | 2.49 | 0.49 | ||||
SCC antigen (mean) | 1.66 | 2.33 | 0.112 |
. | . | . | Relapse free . | Recurrent . | . | P value . | |
---|---|---|---|---|---|---|---|
. | . | . | n = 15 . | . | n = 7 . | . | . |
Mean age | 61.7 | 58.7 | 0.832 | ||||
Sex | |||||||
Male | 14 | 7 | |||||
Female | 1 | 0 | 0.259 | ||||
Plasma miR-21 | |||||||
(Mean) | 1.27 | 1.7 | 0.04 | ||||
Stage | |||||||
III | 6 | 2 | |||||
IV | 9 | 5 | 0.49 | ||||
Subsite | |||||||
Oro-hypopharynx | 13 | 5 | |||||
Others | 2 | 2 | 0.378 | ||||
HPV status positive | 3 | 1 | |||||
Negative | 12 | 5 | 0.105 | ||||
Brinkman index | |||||||
≦400 | 4 | 1 | |||||
>400 | 11 | 5 | 0.651 | ||||
Sake index (mean) | 47.1 | 73.5 | 0.805 | ||||
CRP (mean) | 0.413 | 2.059 | 0.49 | ||||
NLR (mean) | 2.75 | 2.49 | 0.49 | ||||
SCC antigen (mean) | 1.66 | 2.33 | 0.112 |
NLR: neutrophil–lymphocyte ration
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.